Wedmont Private Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $933K | Buy |
12,090
+2,230
| +23% | +$172K | 0.04% | 275 |
|
|
2025
Q1 | $684K | Buy |
9,860
+1,512
| +18% | +$105K | 0.04% | 306 |
|
|
2024
Q4 | $613K | Buy |
8,348
+398
| +5% | +$29.2K | 0.03% | 320 |
|
|
2024
Q3 | $513K | Sell |
7,950
-754
| -9% | -$48.7K | 0.03% | 345 |
|
|
2024
Q2 | $792K | Buy |
8,704
+515
| +6% | +$46.9K | 0.05% | 241 |
|
|
2024
Q1 | $762K | Buy |
8,189
+405
| +5% | +$37.7K | 0.06% | 236 |
|
|
2023
Q4 | $589K | Buy |
7,784
+4,514
| +138% | +$342K | 0.05% | 270 |
|
|
2023
Q3 | $238K | Buy |
3,270
+319
| +11% | +$23.3K | 0.02% | 431 |
|
|
2023
Q2 | $276K | Buy |
2,951
+325
| +12% | +$30.3K | 0.03% | 396 |
|
|
2023
Q1 | $217K | Buy |
+2,626
| New | +$217K | 0.03% | 423 |
|
|
2022
Q3 | – | Sell |
-2,689
| Closed | -$256K | – | 383 |
|
|
2022
Q2 | $256K | Buy |
2,689
+936
| +53% | +$89.1K | 0.06% | 275 |
|
|
2022
Q1 | $211K | Buy |
1,753
+10
| +0.6% | +$1.2K | 0.05% | 306 |
|
|
2021
Q4 | $210K | Buy |
+1,743
| New | +$210K | 0.06% | 225 |
|